Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 7;10(2):196.
doi: 10.3390/jcm10020196.

Clostridioides difficile Infection in Chronic Kidney Disease-An Overview for Clinicians

Sylwia Dudzicz  1 , Andrzej Wiecek  1 , Marcin Adamczak  1
Affiliations
Review

Clostridioides difficile Infection in Chronic Kidney Disease-An Overview for Clinicians

Sylwia Dudzicz et al. J Clin Med. .

Abstract

Increased incidence of Clostridioides difficile infection (CDI), occurrence of severe and complicated CDI, and more frequent occurrence of drug-resistant, recurrent or non-hospital CDI has become a worldwide clinical problem. CDI is more common in patients with chronic kidney disease (CKD) than in the general population. CDI seems to be associated with frequent hospitalization, frequently used antibiotic therapy, dysbiosis, and abnormalities of the immune system observed in CKD patients. Dysbiosis is a common disorder found in CKD patients. It may be related to insufficient fiber content in the diet, reduced amount of consumed fluids and often reduced physical activity, constipation, impaired gastrointestinal motility, multidrug pharmacotherapy, and uremic milieu in CKD stage 5. In patients with CKD the clinical manifestations of CDI are similar to the general population; however, more frequent recurrence of CDI and higher prevalence of severe CDI are reported. Moreover, the increase in CDI related mortality is observed more in CKD patients than in the general population. The aim of this review paper is to summarize the current knowledge concerning the epidemiology, pathogenesis, clinical picture, and prevention and treatment in CKD patients.

Keywords: Clostridioides difficile infection; chronic kidney disease; dysbiosis; probiotic.

PubMed Disclaimer

Conflict of interest statement

Marcin Adamczak received a lecturer fee from Sanprobi. The other authors declare no conflict of interest.

References

    1. Smits W.K., Lyras D., Lacy D.B., Wilcox M.H., Kuijper E.J. Clostridium difficile infection. Nat. Rev. Dis. Prim. 2016;2:1–20. doi: 10.1038/nrdp.2016.20. - DOI - PMC - PubMed
    1. Valiente E., Cairns M.D., Wren B.W. The Clostridium difficile PCR ribotype 027 lineage: A pathogen on the move. Clin. Microbiol. Infect. 2014;20:396–404. doi: 10.1111/1469-0691.12619. - DOI - PubMed
    1. Carlson P.E., Walk S.T., Bourgis A.E., Liu M.W., Kopliku F., Lo E., Young V.B., Aronoff D.M., Hanna P.C. The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. Anaerobe. 2013;24:109–116. doi: 10.1016/j.anaerobe.2013.04.003. - DOI - PMC - PubMed
    1. Pituch H., Obuch-Woszczatyński P., Lachowicz D., Wultańska D., Karpiński P., Młynarczyk G., Van Dorp S.M., Kuijper E.J. The Polish Clostridium difficile Study Group Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Eurosurveillance. 2015;20:30025. doi: 10.2807/1560-7917.ES.2015.20.38.30025. - DOI - PubMed
    1. Guh A.Y., Mu Y., Winston L.G., Johnston H., Olson D., Farley M.M., Wilson L.E., Holzbauer S.M., Phipps E.C., Dumyati G.K., et al. Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes. N. Engl. J. Med. 2020;382:1320–1330. doi: 10.1056/NEJMoa1910215. - DOI - PMC - PubMed

LinkOut - more resources